关注
Gavin Whitlock
Gavin Whitlock
Sandexis
在 sandexis.co.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
A Alex, DS Millan, M Perez, F Wakenhut, GA Whitlock
MedChemComm 2 (7), 669-674, 2011
3242011
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform
B Desai, K Dixon, E Farrant, Q Feng, KR Gibson, WP van Hoorn, J Mills, ...
Journal of medicinal chemistry 56 (7), 3033-3047, 2013
1602013
Catalytic asymmetric hydroboration with heterotopic PN ligands: Trends in enantioselectivity with increased steric demand
JM Valk, GA Whitlock, TP Layzell, JM Brown
Tetrahedron: Asymmetry 6 (10), 2593-2596, 1995
1271995
Enantioselective Synthesis of ent-Stellettamide A via a Novel Dipolar Cycloaddition Reaction of (Trimethylsilyl) diazomethane.
GA Whitlock, EM Carreira
The Journal of Organic Chemistry 62 (23), 7916-7917, 1997
791997
Potent and selective nonpeptidic inhibitors of procollagen C-proteinase
PV Fish, GA Allan, S Bailey, J Blagg, R Butt, MG Collis, D Greiling, ...
Journal of medicinal chemistry 50 (15), 3442-3456, 2007
752007
Novel amino-pyrazole ureas with potent in vitro and in vivo antileishmanial activity
CE Mowbray, S Braillard, W Speed, PA Glossop, GA Whitlock, KR Gibson, ...
Journal of medicinal chemistry 58 (24), 9615-9624, 2015
722015
Asymmetric synthesis of cyclic ethers by rearrangement of oxonium ylides generated from chiral copper carbenoids
JS Clark, M Fretwell, GA Whitlock, CJ Burns, DNA Fox
Tetrahedron letters 39 (1-2), 97-100, 1998
701998
Metalloprotease inhibitors
KN Dack, MJ Fray, GA Whitlock, ML Lewis, NM Thomson
US Patent 6,511,993, 2003
692003
A concise enantioselective synthesis of the fungal metabolite (+)-decarestrictine L
JS Clark, TC Fessard, GA Whitlock
Tetrahedron 62 (1), 73-78, 2006
642006
A short synthesis of (±)-decarestrictine L
JS Clark, GA Whitlock
Tetrahedron letters 35 (34), 6381-6382, 1994
621994
Chloroquine–astemizole hybrids with potent in vitro and in vivo antiplasmodial activity
CC Musonda, GA Whitlock, MJ Witty, R Brun, M Kaiser
Bioorganic & medicinal chemistry letters 19 (2), 481-484, 2009
582009
Quantitative chemical proteomic profiling of ubiquitin specific proteases in intact cancer cells
JA Ward, L McLellan, M Stockley, KR Gibson, GA Whitlock, C Knights, ...
ACS chemical biology 11 (12), 3268-3272, 2016
572016
Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of …
P Jones, RI Storer, YA Sabnis, FM Wakenhut, GA Whitlock, KS England, ...
Journal of Medicinal Chemistry 60 (2), 767-786, 2017
532017
Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity
CC Musonda, GA Whitlock, MJ Witty, R Brun, M Kaiser
Bioorganic & medicinal chemistry letters 19 (2), 401-405, 2009
512009
Enantioselective Synthesis of ent‐Stellettamide A: Asymmetric Dipolar Cycloadditions with Me3SiCHN2
GA Whitlock, EM Carreira
Helvetica chimica acta 83 (8), 2007-2022, 2000
462000
Pyrazolopyridines and pyrazolopyrimidines
JW Coe, CM Dehnhardt, P Jones, YA Sabnis, JW Strohbach, ...
US Patent 9,518,052, 2016
432016
Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition
PV Fish, C Deur, X Gan, K Greene, D Hoople, M Mackenny, KS Para, ...
Bioorganic & medicinal chemistry letters 18 (8), 2562-2566, 2008
432008
DNDI-6148: a novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis
CE Mowbray, S Braillard, PA Glossop, GA Whitlock, RT Jacobs, J Speake, ...
Journal of medicinal chemistry 64 (21), 16159-16176, 2021
402021
Understanding CYP2D6 interactions
MJ de Groot, F Wakenhut, G Whitlock, R Hyland
Drug discovery today 14 (19-20), 964-972, 2009
402009
Compounds
PV Fish, MJ Fray, A Stobie, F Wakenhut, GA Whitlock, MD Andrews, ...
US Patent 7,378,436, 2008
402008
系统目前无法执行此操作,请稍后再试。
文章 1–20